City contributes to Europe AMD study

Tests and therapies for AMD will be developed by a €16m European-wide project involving City, University of London.

Novel approaches would be adopted to see if subtle changes in AMD can be accurately detected over time, studying 700 patients from 20 clinical sites across Europe.

Researchers at City will contribute to the MACUSTAR project over the course of a five-year project to help reduce the burden of AMD in healthcare, according to a statement. In total, €350,000 of the funding has been pledged to City, to assess a series of tests of visual function in conjunction with colleagues at UCL and Moorfields Eye Hospital.